与单片式丙烯酸人工晶状体相关的亚急性起病中毒性眼前段综合征暴发
这项回顾性多中心观察性病例系列调查了2015年1月至2016年3月期间因植入特定型号单片式丙烯酸人工晶状体后发生亚急性起病中毒性眼前段综合征(TASS)的病例,独立调查委员会直接向184家机构的304只眼索取数据,最终确认147例TASS,平均起病时间为术后13.1±16.4天,总体治疗结局良好。
要点
- 植入AcrySof ReSTOR、ReSTOR toric或AcrySof IQ toric SN6AT6-9人工晶状体后出现亚急性起病TASS暴发。
- 147例TASS的平均起病时间为术后13.1±16.4天,其中84眼(57.1%)在术后7天内出现症状。
- 104眼(70.7%)仅药物治疗,43眼(29.3%)需手术干预,总体治疗结局良好。
核心结论
- 植入特定型号人工晶状体后发生了大规模亚急性起病TASS暴发,总体治疗结局良好。
研究设计与样本
- 回顾性、多中心、观察性病例系列,针对2015年1月至2016年3月期间报告至制造商的病例。
- 独立调查委员会(非Alcon公司)直接向184家机构的304只眼的手术医生索取数据。
- 最终从130家机构的201只眼中获得数据采集同意,排除感染性眼内炎和不确定病例后确认147例亚急性起病TASS。
主要发现
- 147例TASS中,植入AcrySof ReSTOR或ReSTOR toric人工晶状体者94眼(63.9%),植入AcrySof IQ toric SN6AT6-9人工晶状体者53眼(36.1%)。
- 平均起病时间为术后13.1±16.4天(范围1-88天),84眼(57.1%)在术后7天内出现症状。
- 典型临床表现为术后数天临床过程平稳后前房炎症轻至中度加重。
- 104眼(70.7%)仅接受药物治疗,43眼(29.3%)接受手术,包括前房冲洗、玻璃体切除术和人工晶状体取出。
- 末次随访时平均最佳矫正视力(BCVA)为-0.012±0.175 logMAR,显著优于TASS起病时BCVA(0.158±0.351 logMAR),与炎症发生前BCVA(-0.004±0.162 logMAR)无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the results of a clinical investigation after an outbreak of subacute-onset toxic anterior segment syndrome (TASS) after implantation of single-piece acrylic intraocular lenses (IOLs), which then were recalled voluntarily from the market. DESIGN: Retrospective, multicenter, observational case series. PARTICIPANTS: Cases reported to the manufacturer from January 2015 through March 2016 of unusual ocular inflammation after cataract surgery using AcrySof ReSTOR, ReSTOR toric, or AcrySof IQ toric SN6AT6-9 IOLs (Alcon Laboratories, Inc., Fort Worth, TX). METHODS: The independent investigation committee, not Alcon, directly requested the surgeons for data on 304 eyes from 184 facilities. RESULTS: Consent for data collection was obtained for 201 eyes from 130 facilities. By excluding cases with infectious endophthalmitis and inconclusive cases, the investigation committee identified 147 cases of subacute-onset TASS. AcrySof ReSTOR or ReSTOR toric IOLs and AcrySof IQ toric SN6AT6-9 IOLs were implanted in 94 eyes (63.9%) and 53 eyes (36.1%), respectively. The mean onset time was 13.1±16.4 days after surgery (range, 1-88 days), with 84 eyes (57.1%) demonstrating symptoms within 7 days after surgery. Typical clinical symptoms were mild to moderate exacerbation of inflammation in the anterior chamber after an uneventful clinical course for a few days after surgery. One hundred four eyes (70.7%) were treated with medication alone, and 43 eyes (29.3%) underwent surgery, including irrigation of the anterior chamber, vitrectomy, and removal of the IOL. The mean best-corrected visual acuity (BCVA) at the final visit (-0.012±0.175 logarithm of the minimum angle of resolution [logMAR]) was significantly better than the BCVA at the onset of TASS (0.158±0.351 logMAR) and did not differ from that before inflammation developed (-0.004±0.162 logMAR). Overall treatment outcomes were favorable. CONCLUSIONS: A large-scale outbreak of subacute-onset TASS developed after implantation of a specific model of IOL.
引用
- Oshika T, Eguchi S, Goto H, et al. Outbreak of Subacute-Onset Toxic Anterior Segment Syndrome Associated with Single-Piece Acrylic Intraocular Lenses. Ophthalmology. 2017. PMID: 28110952. doi:10.1016/j.ophtha.2016.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。